D-0110-2018 Class III Terminated
FDA drug recall D-0110-2018 was initiated by Osmotica Pharmaceutical Corp on Dec 18, 2017 and is designated Class III. Reason for recall: Subpotent Drug The recall status is terminated (terminated May 1, 2019). Affected quantity: 10064 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 27, 2017
- Initiation Date
- Dec 18, 2017
- Termination Date
- May 1, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 10064 bottles
Product description
Methylphenidate Hydrochloride Extended-release Tablets, USP 27 mg, 100-count bottles, Rx Only, Trigen Laboratories, LLC. Bridgewater, NJ 08807, NDC 13811-707-10
Reason for recall
Subpotent Drug
Distribution pattern
Nationwide
Code information
Lot #: 170027A, Exp. 02/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0110-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026